← Back to Search

Behavioural Intervention

Virtual Cardiac Rehab Program for Heart Disease (mTECH REHAB Trial)

N/A
Recruiting
Led By Lena Mathews, MD, MHS
Research Sponsored by Johns Hopkins University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Individuals admitted to the hospital for the following conditions or interventions during the index admission: Acute myocardial infarction (STEMI or NSTEMI type 1), Coronary artery bypass grafting, and coronary artery angioplasty/stenting.
18 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 16 weeks
Awards & highlights

mTECH REHAB Trial Summary

This trial is testing whether a multi-component virtual cardiac rehabilitation program can help improve cholesterol levels, cardiovascular health, quality of life and mental health for patients recently diagnosed with atherosclerotic cardiovascular disease.

Who is the study for?
This trial is for adults who've been hospitalized with heart issues like a heart attack or had procedures like bypass grafting or stenting. It's not for those who don't speak English/Spanish, have severe valve disease, physical disabilities preventing exercise, uncontrolled high blood pressure, certain heart complications, severe depression, sensory impairments that hinder using the program, pregnant women or if they're clinically unstable.Check my eligibility
What is being tested?
The study tests a virtual cardiac rehab program alongside usual care to see if it betters patients' functional status and overall heart health compared to just standard care. This includes looking at cholesterol levels and mental well-being in people recently diagnosed with cardiovascular diseases.See study design
What are the potential side effects?
Since this is a non-drug intervention focusing on rehabilitation through virtual means there may be minimal side effects directly from the program itself; however indirect effects might include discomfort due to new exercises or stress from technology use.

mTECH REHAB Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I was hospitalized for a heart attack or had a procedure to open blocked arteries.
Select...
I am 18 years old or older.

mTECH REHAB Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~16 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 16 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The difference in functional status as measured by 6 minute walk test
Secondary outcome measures
Cost of Care as assessed by a Markov Model of Cost-effectiveness
Difference in smoking rates as measured by the proportion of current tobacco users
The difference in Health Literacy as measured by The (e) Health Literacy Scale (eHEALS)
+26 more

mTECH REHAB Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Corrie Virtual Cardiac Rehabilitation ProgramExperimental Treatment1 Intervention
Receives Corrie Virtual Cardiac Rehabilitation Program and usual care
Group II: Usual CareActive Control1 Intervention
Receives usual care. Usual care is defined as care according to the patients care team's standard practice

Find a Location

Who is running the clinical trial?

Johns Hopkins UniversityLead Sponsor
2,246 Previous Clinical Trials
14,816,266 Total Patients Enrolled
27 Trials studying Coronary Artery Disease
56,279 Patients Enrolled for Coronary Artery Disease
American Heart AssociationOTHER
320 Previous Clinical Trials
4,931,984 Total Patients Enrolled
12 Trials studying Coronary Artery Disease
1,639 Patients Enrolled for Coronary Artery Disease
Apple Inc.Industry Sponsor
20 Previous Clinical Trials
1,640,998 Total Patients Enrolled
1 Trials studying Coronary Artery Disease
200 Patients Enrolled for Coronary Artery Disease

Media Library

Corrie Virtual Cardiac Rehabilitation Program (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05238103 — N/A
Coronary Artery Disease Research Study Groups: Corrie Virtual Cardiac Rehabilitation Program, Usual Care
Coronary Artery Disease Clinical Trial 2023: Corrie Virtual Cardiac Rehabilitation Program Highlights & Side Effects. Trial Name: NCT05238103 — N/A
Corrie Virtual Cardiac Rehabilitation Program (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05238103 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are recruitment efforts for this experiment still ongoing?

"According to clinicaltrials.gov, this study is no longer recruiting patients - initially posted on December 1st 2022 and last updated on November 9th 2022. Nonetheless, there are over a thousand other trials actively looking for participants at the present time."

Answered by AI
~212 spots leftby Dec 2024